[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][C][N][C][C][N][Branch1][Branch1][C][C][Ring1][=Branch1][C][C][=C][Branch2][Ring2][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][=Branch1][C][=O][N][C][=C][C][=Branch1][=Branch2][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][N][C][C][=C][N][=C][C][=Branch1][=Branch1][=C][Ring1][=Branch1][O][C][C][=C][N][Ring1][Branch2][C][Branch1][C][F][Branch1][C][F][F]"}, {"from": "gpt", "value": "The molecule is a secondary carboxamide resulting from the formal condensation of the carboxy group of 4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzoic acid with the primary amino group of N(3)-[(4-methoxy-1H-pyrrolo[2,3-b]pyridin-5-yl)methyl]-4-methylbenzene-1,3-diamine. It is a potent inhibitor of discoidin domain receptor tyrosine kinase 1 and 2 (DDR1/2) with IC50 = 47 nM and 145 nM, respectively. It has a role as an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It is a member of (trifluoromethyl)benzenes, a N-alkylpiperazine, an aromatic ether, a member of benzamides, a pyrrolopyridine and a secondary carboxamide."}]